UCB's Global Corporate Website

UCB at ICD 2021: Exploring the unmet needs of people living with psoriasis

picture of author Jeron Evans
Posted by
Jeron Evans, Patient Value Immunology & US Solutions
The XIII International Congress of Dermatology (ICD) will bring together leading dermatologists from 10-13 November 2021, to highlight and discuss the latest opportunities and challenges in the world of dermatology. As we look forward to taking part in this congress, we’re also reminded of what a truly exciting year it has been for UCB to share new scientific data, connect with clinicians and be inspired by the dermatology community at events like this.

This year’s ICD will be hosted virtually – a first for the congress – and will enable delegates to learn and engage with dermatology experts from all over the world, as well as providing access to on-demand recordings of sessions up to a year after the event.

UCB is proud to be a platinum sponsor at ICD 2021 and will share insights into the latest data from our dermatology research program during 12 scientific presentations, including six oral presentations and six digital posters. There will also be two UCB sponsored symposia; ‘From Noise to Signal in Psoriasis’ will take a deeper dive into the needs and expectations of psoriasis patients and the impact on their overall quality of life. Our second symposium ‘Addressing Unmet Patient Needs in Psoriasis: Women’s Health and Long-Term Disease Control’ will explore the unique challenges women with psoriasis face and the importance of shared decision-making. Attendees will also have the opportunity to visit the UCB virtual booth and connect with UCB team members to explore our ongoing commitment to making a difference to the lives of people with immuno-dermatological diseases.

Stay up to date with the latest UCB news at ICD 2021 through our social media channels (Twitter, LinkedIn) and get involved using #ICD2021.

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.